BSE Circulars (21083)
Bombay Stock Exchange circulars covering trading rules, listing requirements, compliance guidelines, market operations, and regulatory changes for market participants.
| Date | Circular | Tags | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
BSE announces Demat Auction Settlement No. 835 dated March 10, 2026, listing securities of various companies scheduled for auction due to … | |||||||||||||||
BSE announces Demat Auction Settlement No. 835 dated March 10, 2026, listing securities of various companies scheduled for auction due to short delivery or other settlement obligations. | |||||||||||||||
BSE announces the trading and settlement schedule for the Securities Lending and Borrowing (SLB) segment for the period April 1 to April 30, … | |||||||||||||||
BSE announces the trading and settlement schedule for the Securities Lending and Borrowing (SLB) segment for the period April 1 to April 30, 2026, covering settlement numbers SL-002/26-27 to SL-021/26-27.
| |||||||||||||||
BSE lists new commercially placed securities including Commercial Papers from DSP Finance, Reliance Retail Ventures, Standard Chartered … | |||||||||||||||
BSE lists new commercially placed securities including Commercial Papers from DSP Finance, Reliance Retail Ventures, Standard Chartered Securities, Birla Group Holdings, and Bajaj Finance on its Debt Segment effective March 10, 2026.
| |||||||||||||||
HDFC Trustee Company Limited has decided to change the fundamental attributes of HDFC Non-Cyclical Consumer Fund, renaming it to HDFC … | |||||||||||||||
HDFC Trustee Company Limited has decided to change the fundamental attributes of HDFC Non-Cyclical Consumer Fund, renaming it to HDFC Consumption Fund with a broader consumption theme.
| |||||||||||||||
BSE revises price bands for 12 scrips effective March 11, 2026, with bands ranging from 2% to 20% for various equity securities. | |||||||||||||||
BSE revises price bands for 12 scrips effective March 11, 2026, with bands ranging from 2% to 20% for various equity securities.
| |||||||||||||||
BSE revises price bands for 12 listed scrips effective March 11, 2026, with bands ranging from 2% to 20% across various equity securities. | |||||||||||||||
BSE revises price bands for 12 listed scrips effective March 11, 2026, with bands ranging from 2% to 20% across various equity securities.
| |||||||||||||||
BSE publishes clarifications from RailTel Corporation of India Ltd. and Uno Minda Limited regarding news items appearing in financial media, … | |||||||||||||||
BSE publishes clarifications from RailTel Corporation of India Ltd. and Uno Minda Limited regarding news items appearing in financial media, including RailTel's MoU with GAIL for digital infrastructure and Uno Minda's new trumpet horn product launch.
| |||||||||||||||
BSE sought clarifications from RailTel Corporation of India Ltd. and Uno Minda Limited regarding news articles and share price movements. … | |||||||||||||||
BSE sought clarifications from RailTel Corporation of India Ltd. and Uno Minda Limited regarding news articles and share price movements. RailTel confirmed a non-binding MoU with GAIL for digital infrastructure, while Uno Minda clarified a product launch news item.
| |||||||||||||||
BSE received clarifications from Emcure Pharmaceuticals Ltd and Landmark Global Learning Ltd regarding significant increase in volume/price … | |||||||||||||||
BSE received clarifications from Emcure Pharmaceuticals Ltd and Landmark Global Learning Ltd regarding significant increase in volume/price movement of their securities, both companies stating the movement is market-driven with no undisclosed material information.
| |||||||||||||||
Emcure Pharmaceuticals and Landmark Global Learning submitted clarifications to BSE Surveillance Department stating no undisclosed … | |||||||||||||||
Emcure Pharmaceuticals and Landmark Global Learning submitted clarifications to BSE Surveillance Department stating no undisclosed price-sensitive information exists behind recent significant volume/price movements in their scrips.
| |||||||||||||||